News
Glenmark Pharma reports 12.8% revenue growth in FY25 to ₹13,322 crore, driven by strong performance in India and Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback